Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 3.87 M3.3 M3.93 M3.61 M 14.71 M Research & development ———— — Operating income 41.2 M39.5 M43.81 M41.87 M 166.38 M Non-Operating Income, Total 2.64 M2.66 M2.6 M2.53 M 10.43 M Interest expense, net of interest capitalized 44.8 M42.68 M39.93 M41.61 M 169.03 M Non-Operating Income, excl. Interest Expenses -42.16 M-40.02 M-37.34 M-39.08 M -158.6 M Unusual income/expense ———— — Pretax income 11.97 M11.78 M12.64 M11.01 M 47.4 M Equity in earnings ———— — Taxes 2.46 M2.33 M2.5 M3.84 M 11.14 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 9.51 M9.45 M10.14 M7.17 M 36.26 M Discontinued operations ———— — Net income 9.51 M9.45 M10.14 M7.17 M 36.26 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 9.51 M9.45 M10.14 M7.17 M 36.26 M Basic earnings per share (Basic EPS) 0.150.150.160.12 0.58 Diluted earnings per share (Diluted EPS) 0.150.150.160.11 0.57 Average basic shares outstanding 62.74 M62.86 M62.91 M62.87 M — Diluted shares outstanding 62.95 M63.06 M63.25 M63.22 M — EBITDA -4.23 M-3.09 M2.16 M-104 K -5.26 M EBIT -5.25 M-4.05 M1.94 M-505 K -7.88 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 1.02 M961 K226 K401 K 2.61 M